G-protein-coupled receptors mediate the biological effects of many hormones and neurotransmitters and are important pharmacological targets 1 . They transmit their signals to the cell interior by interacting with G proteins. However, it is unclear how receptors and G proteins meet, interact and couple. Here we analyse the concerted motion of G-protein-coupled receptors and G proteins on the plasma membrane and provide a quantitative model that reveals the key factors that underlie the high spatiotemporal complexity of their interactions. Using two-colour, single-molecule imaging we visualize interactions between individual receptors and G proteins at the surface of living cells. Under basal conditions, receptors and G proteins form activity-dependent complexes that last for around one second. Agonists specifically regulate the kinetics of receptor-G protein interactions, mainly by increasing their association rate. We find hot spots on the plasma membrane, at least partially defined by the cytoskeleton and clathrin-coated pits, in which receptors and G proteins are confined and preferentially couple. Imaging with the nanobody Nb37 suggests that signalling by G-protein-coupled receptors occurs preferentially at these hot spots. These findings shed new light on the dynamic interactions that control G-protein-coupled receptor signalling.
2,3
. However, there are still unanswered questions about the stability of these interactions and the occurrence of G-protein-coupled receptor (GPCR) signalling subdomains at the plasma membrane (see Supplementary Discussion). To address these questions, we visualized individual receptors and G proteins at the surface of living cells with high spatial (around 20 nm) and temporal (around 30 ms) resolution 4 . As a model, we chose the α 2A -adrenergic receptor (α 2A -AR), a prototypical family-A GPCR that couples strongly with the inhibitory G protein (G i ) 2 . The α 2A -AR and a pertussis toxin (PTX)-insensitive Gα i1 construct were specifically labelled with two different organic fluorophores via a SNAP 5 and a CLIP 6 tag, respectively (Fig. 1a) ; both constructs were fully functional (Extended Data  Fig. 1a, b) . These constructs were transiently expressed at low physiological densities (0.55 ± 0.10 and 0.51 ± 0.09 molecules per μm 2 , respectively) in CHO cells (cultured with PTX to inactivate endogenous G i and G o proteins) and simultaneously imaged using fast two-colour single-molecule microscopy combined with single-particle tracking 4 ( Fig. 1b and Supplementary Videos 1, 2). The labelling efficiencies were approximately 90% (extracellular) and 80% (intracellular); non-specific labelling was below 1% (Extended Data Fig. 1c-e) .
Individual α 2A -AR trajectories were evaluated by mean square displacement (MSD) analysis (corrected for localization error; see Supplementary Methods), which revealed high heterogeneity and features of anomalous diffusion 7 . Under basal conditions, 11% of the receptors were virtually immobile, while 38% were confined (subdiffusion), 45% underwent simple Brownian motion (normal diffusion) and 6% had directional motion (super-diffusion) (Extended Data Fig. 2 ). Gα i subunits showed a significantly different diffusion pattern, with a larger immobile fraction (37%) (Extended Data Fig. 2c, d) . Stimulation with the full agonist noradrenaline or brimonidine (UK-14,304) caused a small but significant change in the overall diffusion pattern of Gα i but not of α 2A -AR (Extended Data Fig. 2d ). Similar results were obtained for a second receptor-G protein pair (the β 2 -adrenergic receptor (β 2 -AR) and Gα s ), but no significant differences were observed upon stimulation with the full agonist isoproterenol (Extended Data Fig. 2d ).
Birmingham B15 2TT, UK. 6 Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Birmingham B15 2TT, UK. ) derived from the HMM analysis. Each state is represented by a solid circle; circle area and arrow thickness are proportional to occupancy and transition probability, respectively. Differences were statistically significant by two-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 versus corresponding state of We then analysed the trajectories with an algorithm based on hidden Markov models (HMMs) 8 , which assumes that particles switch among discrete diffusive states following a stochastic process. We found that both receptors and G proteins frequently switched among at least four distinguishable states (S1-S4) characterized by distinct diffusion coefficients (D) and ranging from virtually immobile (S1) to fastdiffusing (S4) (Fig. 1c-f and Extended Data Table 1 ). Overall, the results were consistent with those of the MSD analysis. We hypothesized that the two slowest states (S1 and S2) resulted from trapping of receptors and G proteins in small membrane compartments and, based on the corresponding D values and average dwell times, we estimated compartment radiuses of less than 50 nm for S1 and around 270 nm for S2 (see Supplementary Methods). We obtained similar results, albeit with some differences, when we analysed the structurally non-related integral membrane protein CD86 4 ( Fig. 1f , Extended Data Fig. 2d and Extended Data Table 1 ), indicating that such diffusion behaviour is not unique to GPCRs and G proteins.
Density maps of single-molecule localizations revealed areas that were preferentially explored or avoided by α 2A -ARs and Gα i subunits (Extended Data Fig. 3a and Supplementary Video 3). To better characterize these areas, we generated dynamic maps from the trajectories, reporting local D and potential energy (V) values 9 . This analysis revealed a complex dynamic landscape at the plasma membrane, with high-potential areas, which were rapidly left by α 2A -ARs and Gα i subunits, and low-potential areas, where they tended to be trapped (Extended Data Fig. 3b , dark areas; see Extended Data Fig. 1f for control) . There was a partial but consistent overlap between the potential energy maps of α 2A -ARs and of Gα i subunits (Extended Data Fig. 3c ). To quantify this overlap, we measured the relative potential energy values (V L,rel ) of Gα i subunits at the sites of α 2A -AR localization and vice versa; both were significantly lower than for random localizations (P = 0.0072 and 0.0025, respectively) or when compared to CD86 (P = 0.039) (Fig. 2a) . Importantly, receptor-G protein interactions occurred preferentially at the shared low potential energy areas (hot spots), as indicated by negative V L,rel values (Fig. 2b) . Similar results were obtained for β 2 -ARs and Gα s subunits (Extended Data Fig. 4a, b) .
To investigate factors that might be responsible for this complex diffusion dynamics, we imaged both the cytoskeleton and clathrin-coated pits (CCPs) underneath the plasma membrane. The trajectories of α 2A -ARs tended to avoid microtubules and actin fibres, as suggested by negative colocalization index values (Fig. 2c, d , Supplementary Videos 4, 5) . This behaviour is in agreement with the fence-and-picket model 10 , according to which the plasma membrane is parcelled into subdomains by the cytoskeleton ('fences') and transmembrane proteins ('pickets'). Moreover, most trajectories tended to avoid CCPs (Fig. 2e , Supplementary Video 6). At the same time, though, a small fraction of α 2A -ARs either transiently stopped at CCPs (Fig. 2f , arrowheads)-consistent with receptors being recruited to pre-existing CCPs 11 -or were immobile and localized at CCPs. The fraction of CCPs occupied by α 2A -ARs increased upon agonist stimulation (Fig. 2f, right) , Overlays of single-particle trajectories with super-resolved actin images, obtained by photoactivated localization microscopy (PALM) 12 , suggested that the actin mesh underneath the plasma membrane created submicrometre compartments in which α 2A -ARs appeared to be loosely trapped ( Fig. 2g and Supplementary Video 7; radius approximately 100-300 nm, in agreement with estimation based on HMM analysis). Superimposition of PALM images with potential energy maps consistently showed that the low potential areas were often at least partially delimited by actin fibres (Fig. 2h and Extended Data Fig. 3d ). Similar results were obtained for β 2 -ARs (Extended Data Fig. 4c-f ) and Gα i subunits (Extended Data Fig. 5 and Supplementary Video 8) .
Next, we developed a mathematical analysis to estimate the duration of receptor-G protein interactions on the basis of their trajectories. We reasoned that, on average, for two particles undergoing a true interaction, the observed colocalization time (Δt obs ) should correspond to the average duration of true interactions (Δt true ) plus the average duration of random colocalizations (Δt random ) ( Fig. 3a and Extended Data Fig. 6 ). Thus, we deconvolved the observed colocalization times with those of random colocalizations (obtained with CD86 and Gα i subunits) to estimate the distribution of the underlying true receptor-G protein interactions (Fig. 3b and Supplementary Methods). The results were subsequently expressed as normalized relaxation curves, showing the fraction of the interactions that were still ongoing at time t from the beginning of each interaction (Fig. 3c) . The very fast component in Fig. 3b , seen also with the control CD86, corresponds to non-productive interactions and random colocalizations, the rate of which (k np+rc ) did not differ among the conditions tested (Fig. 3d, left) ; we considered the remainder to be productive interactions, that is, interactions that result in the formation of a true complex (see Supplementary Discussion). α 2A -ARs and Gα i subunits underwent some productive interactions under basal conditions (Fig. 3b, c) . Most of these interactions terminated following an exponential decay, while a very small fraction (approximately 3 × 10 −4 ) was stable over the observation time (Fig. 3c) . From a fitting of the major component in Fig. 3c (Fig. 3d , middle and right). Treatment with an inverse agonist (yohimbine) or Gα i inactivation (using a PTX-sensitive construct) suppressed the major fraction of transient productive interactions, suggesting that they resulted from constitutive α 2A -AR activity and required a functional Gα i subunit; by contrast, the small fraction of stable productive interactions was not affected by such treatments (Fig. 3e) . Stimulation with noradrenaline caused a concentrationdependent increase of k on up to approximately 0.2 μm 2 per molecule per s, whereas k off was only marginally affected ( Fig. 3b-d ). This translates into two-dimensional equilibrium dissociation constants (K d ) of about 50 and 6 molecules per μm 2 for basal and stimulated conditions, respectively. On the basis of these results, we estimated that, at the tested densities, around 0.5% (basal) or 5% (stimulated) of all α 2A -ARs were in complex with Gα i subunits at any given time. Similar results were obtained for β 2 -AR-Gα s interactions, although with approximately tenfold lower k on values and no long-lived interactions (Fig. 3f, g ). A panel of α 2A -AR agonists with varying efficacies and affinities revealed statistically significant differences in the estimated k on and, to a lesser extent, k off values (Fig. 3d) . Overall, there was a positive correlation between k on and efficacy (Fig. 3h) . However, there was also a trend towards smaller k on values for higher affinity agonists, considering both full (UK-14,304 versus noradrenaline) and partial (clonidine versus oxymetazoline) agonists with comparable efficacies and dissimilar affinities (Fig. 3d, h ).
By visually inspecting the trajectories, we observed that several α 2A -ARs and Gα i subunits slowed down or stopped during apparent interactions, and then either remained confined or resumed their motion (Fig. 3i , j, left and Supplementary Video 9), whereas the rest retained their mobility (Fig. 3j, right) . A quantitative analysis of the HMM states of α 2A -AR and Gα i trajectories showed that, during the time of interaction, higher fractions of receptors and G proteins were in states S1 (virtually immobile) and S2 (slowly diffusing) (Fig. 3k ) compared to the time when they did not interact. These mobility changes during the short interaction times and the global changes in Gα i diffusion shown in Extended Data Fig. 2d and Extended Data Table 1 are likely to represent distinct phenomena.
To further validate our results, we performed deterministic simulations of GPCR signalling using the estimated microscopic k on and k off values for receptor-G protein interactions. The results agreed well with ensemble (Förster resonance energy transfer, FRET) measurements of α 2A -AR-G i association and dissociation (Extended Data Fig. 7 ). These simulations also suggested that G-protein signalling can be fast only if it occurs while the G protein is still bound to the receptor (Supplementary Data). Moreover, we performed particle-based stochastic simulations of receptors and G proteins diffusing and interacting on a twodimensional surface (Fig. 4a) . Introducing the experimentally measured potential energy (V) landscapes (as in Fig. 2b ) into these simulations doubled the probability of receptor-G protein interactions when compared to conditions of simple Brownian motion (Fig. 4a) .
To investigate whether hot spots for receptor-G protein interactions also occur in a more physiological context, we studied primary human umbilical vein endothelial cells (HUVECs), in which both α 2A -ARs and β 2 -ARs are endogenously expressed and regulate vascular tone 13 . In these cells, both α 2A -AR-Gα i and β 2 -AR-Gα s interactions occurred preferentially at areas of low potential energy (Extended Data Fig. 8a, b ). In addition, receptors and G proteins slowed down or stopped moving during their interactions (Extended Data Fig. 8c ), consistent with our observations in CHO cells.
Finally, we assessed G s activation using the conformation-sensitive nanobody Nb37 14, 15 , which recognizes the active (nucleotide-free) state of the Gα s subunit. In HUVECs transfected with Nb37 fused to enhanced yellow fluorescent protein (EYFP), Nb37 localized preferentially to the sites where β 2 -ARs were concentrated (Fig. 4b) .
The main findings of our study are summarized in Extended Data Fig. 9 . First, our results reveal a complex picture whereby barriers, at least partially constituted by actin fibres, microtubules and CCPs, contribute to the formation of hot spots where both receptors and G proteins are concentrated, and where G protein coupling and signalling preferentially occur. This finding provides a direct visualization of previously postulated GPCR signalling nanodomains 16, 17 . On the basis of our results and simulations, we hypothesize that this complex organization increases both the speed and efficiency of receptor-G protein coupling, while allowing G protein signalling to occur locally.
Second, our data provide direct estimates of the frequency and duration of receptor-G protein interactions in living cells. We find that most receptor-G protein interactions are short-lived (lifetime around 1-2 s). The dependency of these complexes on receptor activation suggests that they are linked to signalling, as does the observation that G protein activation occurs preferentially at the sites of interaction. In addition, we observe a very small fraction of long-lived complexes (lifetime far exceeding 4 s), possibly corresponding to those reported in previous studies 3, 18 . The coexistence of short-and longlived complexes might reconcile earlier contrasting data. Notably, the estimated duration of the short-lived interactions is much longer than the time required for effector activation 2 , which can happen in around 40 ms. Thus, as suggested by our deterministic simulations, it is conceivable that fast effector activation might occur while the G protein is still bound to the receptor 19 . Third, our results reveal that receptor-G protein interactions are regulated by agonists largely at the level of k on . The low k on values measured here also indicate that random collisions seldom lead to the formation of productive receptor-G protein complexes. The fact that k on is regulated by agonists and the low k on values suggest that receptor-G protein interactions are limited not by diffusion, but rather by the major conformational changes that occur during the formation of receptor-G protein complexes 14, [20] [21] [22] (see also Supplementary Discussion). Notably, different agonists induce substantially different k on values, which correlate at least partially with their efficacies. Together with small differences in the k off values, these findings suggest that receptor signalling could potentially be fine-tuned using drugs with tailored effects on the kinetics of receptor-G protein interactions. Finally, our finding that β 2 -AR-Gα s interactions have lower k on values than α 2A -AR-Gα i interactions is consistent with the view that coupling to G s might require a larger conformational change than coupling to G i 23 . In summary, our single-molecule results identify key factors involved in the regulation of receptor-G protein interactions, which may allow receptor signalling to be modified in ways that far exceed the simple receptor blockade or activation that can be achieved with currently available drugs. For example, this might be achieved by modulating the on and off rates of receptor-G protein interactions or by manipulating receptor and G protein mobility or their coupling at the hot spots. These findings also illustrate how GPCR signalling results from dynamic interactions among receptors, G proteins and the complex surrounding membrane environment, which confers flexibility and versatility on this fundamental biological process.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Materials. Cell culture reagents, Lipofectamine 2000, Lipofectamine 3000, TetraSpeck fluorescent beads, fluorescein arsenical hairpin binder (FlAsH) and CellMask Green Plasma Membrane Stain were from Thermo Fisher Scientific. The Effectene transfection reagent was from Qiagen. UK-14,304 and clonidine were from Tocris Bioscience. All other GPCR ligands, pertussis toxin (PTX), 1,2-ethanedithiol (EDT) and guanosine 5′-triphosphate (GTP) were from Sigma-Aldrich. [ 35 S]GTPγS was from PerkinElmer. The fluorescent benzyl guanine derivatives SNAP-Surface 549 (S549-BG) and SNAP-Surface Alexa Fluor 647 (S647-BG) were from New England Biolabs. Live-cell fluorogenic probes for actin (SiR-actin) and tubulin (SiR-tubulin) 25 were from Spirochrome. The silicon-rhodamine benzyl cytosine derivative (SiR-BC) 26 was kindly provided by K. Johnsson (Max Planck Institute for Medical Research). Ultraclean glass coverslips were obtained as previously described 4 . Molecular biology. A plasmid coding for the N-terminally SNAP-tagged α 2A -adrenergic receptor (SNAP-α 2A -AR) was generated by inserting the SNAP tag 5 before the coding sequence of the mouse α 2A -adrenergic receptor. The generation and functional characterization of the N-terminally SNAP-tagged β 2 -adrenergic receptor construct (SNAP-β 2 -AR) have been previously described 4 . A plasmid coding for the rat Gα i1 subunit with the CLIP tag 6 inserted in the αA-αB loop of the α-helical domain between positions 91 and 92 (Gα i -CLIP) was generated by replacing YFP with the CLIP tag in a previously described YFP-tagged Gα i1 construct 27 . The construct additionally harboured the C351I mutation to render it PTX-insensitive 28 . A plasmid coding for the rat Gα s subunit with the CLIP tag inserted between positions 72 and 85 (Gα s -CLIP) was generated by replacing YFP with the CLIP tag in a previously described YFP-tagged Gα s construct 29 . All tagged receptor and Gα subunit constructs behaved like the corresponding wild type in functional assays (Extended Data Fig. 1a, b) . A construct coding for Histagged Nb37 14 was kindly provided by J. Steyaert (VIB). A plasmid coding for the C-terminally EYFP-tagged Nb37 (Nb37-EYFP) was generated by fusing EYFP to the C terminus of Nb37. Plasmids coding for CD86 with either one or two SNAP tags fused to its N terminus have been previously described 4 . Plasmids coding for CD86 with either one or two CLIP tags fused to its C terminus were generated by inserting either one or two copies of the CLIP tag before the stop codon of CD86. Cell culture and transfection. Chinese hamster ovary K1 (CHO-K1) cells (ATCC) were cultured in phenol red-free Dulbecco's modified Eagle's medium (DMEM)/F-12 supplemented with 5% FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin at 37 °C, 5% CO 2 . For single-molecule experiments, CHO-K1 cells were seeded on ultraclean 24-mm glass coverslips in 6-well culture plates at a density of 3 × 10 5 cells per well. Cells were treated with 50 ng/ml pertussis toxin (PTX) to inactivate endogenous Gα i and Gα o proteins. Transfection was performed 24 h after seeding using Lipofectamine 2000. For each well, 0.8 μg SNAP-α 2A -AR or SNAP-β 2 -AR, 0.6 μg Gα i -CLIP or Gα s -CLIP, 0.4 μg Gβ 1 , 0.2 μg Gγ 2 , and 6 μl Lipofectamine 2000 were used. Cells were labelled and imaged by singlemolecule microscopy 4-6 h after transfection to obtain low physiological expression levels 4 . To label CCPs, cells were transfected 24 h before the experiment with GFP-tagged adaptor protein 2 σ2 subunit (AP2-GFP), kindly provided by T. Kirchhausen (Harvard Medical School). Human embryonic kidney 293 (HEK293) cells (ATCC) were cultured in DMEM supplemented with 5% FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin at 37 °C, 5% CO 2 . HEK293 cells were transfected with Effectene, following the manufacturer's instructions. Cell lines have not been authenticated. Cells were routinely tested for mycoplasma contamination by PCR using specific primers.
For the [ For FRET experiments, HEK293 cells were seeded on poly-l-lysine-coated 24-mm coverslips and transfected with the indicated constructs. The α 2A -ARFlash/CFP sensor was used to monitor receptor activation 30 . Co-transfection of α 2A -AR-YFP, Gα i -CFP, Gβ 1 and Gγ 2 was used to monitor G protein recruitment to the receptor 2 . The Gβ 1 -2A-cpV-Gγ 2 -IRES-Gα i2 -mTq2 sensor 31 was used to monitor G i protein activation.
Human umbilical vein endothelial cells (HUVECs) were purchased from Lonza and cultured in complete EGM-2 BulletKit medium (Lonza). HUVECs were plated on ultraclean 24-mm glass coverslips at a density of 3.5 × 10 5 cells per well and transfected with Lipofectamine 3000 using the same DNA amounts indicated for CHO cells. HUVECs were cultured for a maximum of 10 passages. To visualize local G s protein activation at the plasma membrane, HUVECs were transfected 24 h before the experiment with the Nb37-EYFP construct. . Cells were homogenized in lysis buffer (5 mM Tris, 2 mM EDTA, pH 7.4) and then centrifuged at 1,000g for 10 min. The supernatant was collected and centrifuged at 50,000g for 30 min. The remaining pellet was resuspended in binding buffer (100 mM NaCl, 10 mM MgCl 2 , 20 mM HEPES, pH 7.4). All procedures were performed at 4 °C. Protein concentrations were determined using the Bradford assay. Membrane proteins (10 μg) were then incubated with the indicated agonist concentrations and 100 pM [ 35 S]GTPγS for 15-300 s. Non-specific binding was evaluated by adding 10 μM GTP. The samples were then passed through glass fibre filters and radioactivity was determined using a liquid scintillation counter (Beckman LS-1801).
Live-cell protein labelling. Cells were labelled with a combination of a cellimpermeable SNAP substrate (S549-BG), to label cell-surface receptors, and a highly cell-permeable CLIP substrate (SiR-BC) 26 , to label intracellular G proteins. Cells were incubated with 4 μM S549-BG and 8 μM SiR-BC in complete culture medium for 20 min at 37 °C. Cells were then washed three times using complete culture medium, with 5 min incubation after each wash. This protocol gives labelling efficacies of ~90% and ~80% for extracellular SNAP and intracellular CLIP, respectively (Extended Data Fig. 1c, d) .
Actin and tubulin labelling were performed using SiR-actin and SiR-tubulin, respectively, following the manufacturer's protocol. In brief, cells were labelled with 3 μM SiR-actin or SiR-tubulin in the presence of 10 μM verapamil for 20 min at 37 °C, followed by three washes with complete culture medium.
FlAsH labelling was performed as previously described 30 . . Measurements were performed on an Axiovert 200 inverted microscope (Zeiss) equipped with an oil immersion 100× objective (Plan-Neofluar 100×, NA 1.30), a beamsplitter (DCLP505) and a Polychrome IV monochromator and dualemission photometric system (Till Photonics). Transfected HEK293 cells were placed in a microscopy chamber filled with imaging buffer (137 mM NaCl, 5.4 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, pH 7.3). Agonist stimulation was applied using a pressurized rapid superfusion system (ALA-VM8, ALA Scientific Instruments). FRET was monitored as the ratio between YFP (535 ± 15 nm) and CFP (480 ± 20 nm) emission upon CFP excitation at 436 ± 10 nm. The YFP signal was corrected for direct excitation and bleed-through of CFP emission into the YFP channel as previously described 2 . Single-molecule microscopy and PALM. Single-molecule microscopy experiments were performed using total internal reflection fluorescence (TIRF) illumination on a custom Nikon Eclipse Ti TIRF microscope equipped with 405 nm, 488 nm, 561 nm and 640 nm diode lasers (Coherent), a quadruple band excitation filter, a 100× oil-immersion objective (CFI Apo TIRF 100×, NA 1.49), two beam splitters, four separate EMCCD cameras (iXon DU897, Andor), hardware focus stabilization and a temperature control system. Coverslips were mounted in a microscopy chamber filled with imaging buffer. The objective and the sample were maintained at 20 °C by means of a water-cooled inset and an objective ring connected to a thermostat-controlled water bath. Images in the four channels were acquired simultaneously on the four separate EMCCD cameras. Image sequences (400 frames) were taken in crop and frame-transfer mode, resulting in an acquisition speed of 35 frames per s (that is, one image every 28 ms).
PALM imaging was performed by TIRF microscopy immediately after the acquisition for single-particle tracking. In this case, cells were additionally transfected 24 h before the experiment with the photoconvertible probe mEOS-LifeAct (a kind gift from M. Sauer). mEOS was excited at 561 nm, while applying lowintensity 405 nm laser light to induce photoconversion. Ten thousand frames were acquired at a speed of 35 frames per s. Superresolved images were then obtained using the rapidSTORM software 35 .
Images from different channels were registered against each other using a linear piecewise transformation in MATLAB based on reference points obtained with multicolour fluorescent beads (TetraSpeck; 100 nm size). Single-particle tracking and subsequent analyses. Single-particle detection and tracking were performed using the u-track software 36 in MATLAB as previously described 4 . The interchannel localization precision after coordinate registration by linear piecewise transformation was ~20 nm. For the analysis of receptor-G protein interactions, a non-related membrane receptor (CD86) with diffusion characteristics comparable to those of the α 2A -AR was used as negative control and as a reference for random colocalizations 4 . A method
Letter reSeArCH based on deconvolution of the observed interaction times with the LucyRichardson algorithm 37, 38 was then applied to estimate the underlying duration of receptor-G protein interactions (see Supplementary Methods and Extended Data Fig. 6 ).
To investigate the motion of receptors and G proteins during or immediately before or after an interaction (Fig. 3i-k and Extended Data Fig. 8c ), we considered only apparent interactions with duration ≥ 1.1 s, so that random colocalization represented only a small fraction (approximately 15%), based on a comparison between α 2A -AR (noradrenaline 100 μM) and CD86 (used as negative control).
Detailed information about the computational analyses can be found in the Supplementary Methods. Hidden Markov model analysis. A software based on a variational Bayesian treatment of HMMs (vbSPT) 8 was used to identify discrete diffusive states in the single molecule trajectories and to analyse their characteristics. The number of iterations and bootstrapping were set to 25 and 100, respectively. Diffusion coefficients and dwell times derived from the analysis were used to estimate the size of the corresponding nanocompartments on the plasma membrane (see Supplementary Methods). Spatial mapping of receptor and G protein dynamics. Spatial maps of diffusivity (D) and potential energy (V) were obtained using the InferenceMAP software 9 , based on Bayesian inference, considering a physical model of diffusion in a potential field. Only well-adhering cells with a flat plasma membrane were chosen, to avoid artefacts due to uneven distance from the coverslip. The flatness of the plasma membrane was verified by staining with a fluorescent phospholipid (CellMask Green). The analysed areas were partitioned into small regions of variable size by Voronoi tessellation 9 . The number of regions was optimized to avoid areas with a low number of localizations. The obtained potential energy maps were subsequently used to perform particle-based stochastic simulations of receptor-G protein interactions (see Supplementary Methods). Statistics and reproducibility. Statistical analyses were performed using Prism 6 software (GraphPad Software). Differences between two groups were assessed by two-sided Student's t-test. Differences among three or more groups were assessed by one-way or two-way analysis of variance (ANOVA), as appropriate, followed by Tukey's multiple comparison test (with the exception of the data in Fig. 3d , right, which were compared by two-sided unpaired t-test with Bonferroni correction).
Differences in categorical variables were assessed by χ 2 test. Differences were considered significant for P values <0.05. Code availability. MATLAB scripts are available from the corresponding author upon reasonable request. Data availability. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Letter reSeArCH noradrenaline (NA) to test whether the effects observed upon agonist stimulation were specific for Gα i . Differences in d are statistically significant by two-way ANOVA.
# P < 0.05, ## P < 0.01 and #### P < 0.0001 versus the corresponding basal condition and **P < 0.01, ***P < 0.001 and ****P < 0.0001 versus α 2A -AR basal (top) or β 2 -AR basal (bottom) by Tukey's multiple comparison test. Data are mean ± s.e.m. n = 30 (9,273), 17 (6,623), 37 (8, # P < 0.05, ## P < 0.01, ### P < 0.001, #### P < 0.0001 versus random localizations by two-sided paired t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 versus β 2 -AR (basal) by two-sided unpaired t-test. 
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Differences are statistically significant by two-way ANOVA. # P < 0.05, ## P < 0.01, ### P < 0.001 and #### P < 0.0001 versus the corresponding basal condition, and *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 versus α2A-AR basal (for Gαi and CD86) or β2-AR basal (for Gαs) 
Replication
Describe whether the experimental findings were reliably reproduced.
When representative data are shown, the number of times that the experiment has been repeated with similar results has been stated in the figure legend.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The experiments were not randomized. Single-molecule data were analyzed by automated scripts with no user intervention during the analysis.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Single-molecule data were analyzed by automated scripts with no user intervention during the analysis.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this The single-molecule data were analyzed with Matlab (version R2012a) using
